Targeted Gene Name:

MET

microRNA Score: 0.0345

Pathway Score: 0.0656

Disease Micro RNA Tissue/ Cell line MicroRNA regulation Pathway More Details References
Gastric cancer hsa-miR-206 Stomach Down c-MET signaling pathway MicroRNA-206 acts as a tumor suppressor and inhibits the expression of c-Met in gastric cancer.
Zheng et al., 2015
Gastric cancer hsa-miR-1 AGS, SGC-7901 Down c-MET signaling pathway Upregulation of miR-1 in gastric cancer cells inhibits gastric cancer cell proliferation and migration by targeting MET.
Han et al., 2015
Gastric cancer hsa-miR-34a Stomach Down PI3K-Akt signaling pathway MicroRNA-34a suppresses gastric cancer tumourigenesis by down-regulating the expression of MET via the PI3K (phosphoinositide 3-kinase)/PI3K-Akt signaling pathway.
Peng et al., 2014
Lung cancer hsa-miR-206 A-549 Down PI3K-Akt signaling pathway Upregulation of miR-206 decreases cisplatin resistance and epithelial-mesenchymal transition through inactivation of MET/PI3K-Akt signaling pathway.
Chen et al., 2016
Lung cancer hsa-miR-31 A-549 Up PI3K-Akt signaling pathway MicroRNA-31 suppresses the growth of lung adenocarcinoma cancer stem-like cells through inhibition of the MET-PI3K-Akt signaling pathway.
Hou et al., 2016
Nasopharyngeal carcinoma hsa-miR-34c CNE-1, CNE-2, HNE-1, HONE-1 Down c-MET signaling pathway hsa-miR-34c inhibits tumor growth and metastasis in nasopharyngeal carcinoma by suppressing MET.
Li et al., 2015
Breast cancer hsa-miR-335 MCF-7 Down c-MET signaling pathway MicroRNA-335 inhibits breast cancer cell migration by down-regulating the HGF/c-Met pathway.
Gao et al., 2015
Bladder cancer hsa-miR-433 UM-UC-3, T24, 5637 Down PI3K-Akt signaling pathway MicroRNA-433 suppresses the epithelial-mesenchymal transition in bladder cancer by targeting c-Met through controlling PI3K-Akt signaling pathway.
Xu et al., 2016